Efficacy and safety of weekly rifapentine and isoniazid for tuberculosis prevention in Chinese silicosis patients: a randomized controlled trial

MLA

Wenhong Zhang, et al. “Efficacy and Safety of Weekly Rifapentine and Isoniazid for Tuberculosis Prevention in Chinese Silicosis Patients: A Randomized Controlled Trial.” Clinical Microbiology and Infection, vol. 27, Apr. 2021, pp. 576–82. EBSCOhost, https://doi.org/10.1016/j.cmi.2020.06.008.

APA

Wenhong Zhang, Jin-chao Mao, Xi-tian Huang, Limin Cai, Jin-jing Hong, Lingyun Shao, Qiao Ling, Xiao-dan Wang, Miao-yao Lin, Chun-lian Ma, Ke-chuan Pan, Jing Wu, Qingluan Yang, Guan-qing Peng, Tian-zhou Wu, Xue-feng Liu, Tian Jiang, Qiaoling Ruan, Yaojie Shen, & Xiu-zhen Wang. (2021). Efficacy and safety of weekly rifapentine and isoniazid for tuberculosis prevention in Chinese silicosis patients: a randomized controlled trial. Clinical Microbiology and Infection, 27, 576–582. https://doi.org/10.1016/j.cmi.2020.06.008

Chicago

Wenhong Zhang, Jin-chao Mao, Xi-tian Huang, Limin Cai, Jin-jing Hong, Lingyun Shao, Qiao Ling, et al. 2021. “Efficacy and Safety of Weekly Rifapentine and Isoniazid for Tuberculosis Prevention in Chinese Silicosis Patients: A Randomized Controlled Trial.” Clinical Microbiology and Infection 27 (April): 576–82. doi:10.1016/j.cmi.2020.06.008.